Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018

• Date:
  Lundi, 11 juin 2018, Journée Entière
• Lieu:
  European Medicines Agency, Amsterdam, the Netherlands

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

Minutes of the PRAC meeting 11-14 June 2018

Adopted Reference Number: EMA/PRAC/400242/2018

Agenda - PRAC draft agenda of meeting 11-14 June 2018

Draft Reference Number: EMA/PRAC/395628/2018

Agenda and list of speakers - Public Hearing: quinolone and fluoroquinolone medicines

Public hearing on quinolones and fluoroquinolones - Summary of safety concerns and list of questions

Reference Number: EMA/166405/2018

Summary of the EMA public hearing on quinolone and fluoroquinolone antibiotics

Public hearing on quinolone and fluoroquinolone - Written interventions

Reference Number: EMA/225564/2018 Corr. *

Multimedia

The PRAC held a public hearing on quinolone and fluoroquinolone antibiotics on 13 June 2018.

The hearing was broadcast live on 13 June from 13:00 - 18:00 (UK time).

The video recording is available.